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Cbf5 is a pseudouridine synthase that usually acts in a guide RNA-dependent manner as part of H/ACA
small ribonucleoproteins; however archaeal Cbf5 can also act independently of guide RNA in modifying
uridine 55 in tRNA. This guide-independent activity of Cbf5 is enhanced by proteinsNop10 andGar1which
are also found in H/ACA small ribonucleoproteins. Here, we analyzed the specific contribution of Nop10
and Gar1 for Cbf5-catalyzed pseudouridylation of tRNA. Interestingly, both Nop10 and Gar1 not only
increase Cbf5’s affinity for tRNA, but they also directly enhance Cbf5’s catalytic activity by increasing the
kcat of the reaction. In contrast to the guideRNA-dependent reaction, Gar1 is not involved in product release
after tRNAmodification. These results in conjunction with structural information suggest that Nop10 and
Gar1 stabilize Cbf5 in its active conformation; we hypothesize that this might also be true for guide-RNA
dependent pseudouridine formation by Cbf5.
P
seudouridine synthases are found in all domains of life as they catalyze the formation of the most abundant
RNAmodification, the site-specific conversion of uridines to pseudouridines. Based on their structure and
sequence similarities, pseudouridine synthases are classified into six families named by their bacterial
representatives, TruA, TruB, TruD, RsuA and RluA1 as well as the unrelated pseudouridine synthase Pus10
found in archaea and some eukaryotes2. The diversity of pseudouridine synthases allows them to site-specifically
target cellular RNAs such as ribosomal RNA, tRNA as well as small nuclear and small nucleolar RNA in
eukaryotes. Typically, stand-alone pseudouridine synthases functioning as a single protein recognize one or a
small number of related substrate RNA based on structure and/or sequence1. In addition, archaea and eukaryotes
harbor H/ACA small ribonucleoproteins comprised of the pseudouridine synthase Cbf5 (dyskerin in humans),
the accessory proteins Nop10, Gar1 and archaeal L7Ae or eukaryotic Nhp2 as well as an H/ACA guide RNA3,4.
Here, the different H/ACA guide RNAs are responsible for recruiting the target RNAs through specific base-
pairing interactions while Cbf5 remains the catalytic component of the complex5. However, the role of the
accessory proteins Nop10, Gar1 and L7Ae has not yet been fully established.
Pseudouridines are characterized by a C-C glycosidic bond and an additional imino group in the base
which can participate in additional hydrogen bonds. Presumably, these types of additional interactions confer
the increased stability to RNA containing pseudouridines6. Furthermore, pseudouridines near the active
centers of the spliceosome and the ribosome have been implicated in the function of these molecular
machines7,8. While the exact details of the catalytic mechanism are still under investigation, it is very likely
that all pseudouridine synthases employ the same mechanism for pseudouridylation9 since all pseudouridine
synthases share a structurally very similar catalytic domain including a strictly conserved aspartate residue
which may form a covalent bond to the ribose10. In addition, the active site of pseudouridine synthases is
composed of a positively charged residue that interacts with the catalytic aspartate, and an aromatic residue
which forms stacking interactions with the uracil ring1. In agreement with the suggested common catalytic
mechanism, we have recently shown that three families of bacterial pseudouridine synthases are characterized
by a uniformly slow catalytic step11.
Cbf5 is the most complex pseudouridine synthase as it is acting in conjunction with a guide RNA and proteins
Nop10, Gar1, and archaeal L7Ae. The structure of the Pyrococcus furiosus H/ACA small ribonucleoprotein in
presence and absence of substrate RNA provided insight into the molecular architecture of the complex and
suggested possible functions of its components12,13. As mentioned, Cbf5 is the catalytic unit and interacts exten-
sively with the guide RNA. Nop10 binds to Cbf5 close to the active site and has been proposed to stabilize it, but it
also forms some contacts to the guide RNA. Without Nop10, the H/ACA small ribonucleoprotein is inactive in
SUBJECT AREAS:
MOLECULAR BIOLOGY
BIOPHYSICS
ENZYMES
RNA
Received
9 August 2012
Accepted
3 September 2012
Published
17 September 2012
Correspondence and
requests for materials
should be addressed to
U.K. (ute.kothe@uleth.
ca)
SCIENTIFIC REPORTS | 2 : 663 | DOI: 10.1038/srep00663 1
modifying target RNA14,15. Gar1 is the only protein not directly inter-
acting with RNA, instead it can bind to the thumb loop of Cbf5
stabilizing it in an open conformation. Omission of Gar1 limits the
guide RNA-dependent pseudouridylation activity of H/ACA small
ribonucleoproteins to a single round12, presumably because product
release is impaired when Gar1 is not inducing an open conformation
of the thumb loop. Lastly, L7Ae binds to the kink-turn motif in
archaeal H/ACA guide RNA thereby helping to position the guide
RNA and the substrate RNA within the complex16. Interestingly,
archaeal Cbf5 is also able to act in a guide RNA-independent manner
as it can on its own introduce pseudouridines at position 55 in the T
arm of tRNAs like its bacterial homologue TruB17. This activity is
greatly enhanced by the addition of Nop10 and Gar118,19. The sig-
nificance of this guide-independent activity of Cbf5 is not clear as it
has been demonstrated that tRNAs are pseudouridylated in vivo by
another archaeal enzyme, Pus1020.
Here, we ask the question why Cbf5 requires additional proteins,
in particular Nop10 and Gar1, for its optimal function. Answering
this question is not possible by investigating the guide RNA-
dependent reaction of the H/ACA small ribonucleoprotein complex,
as it loses its complete guide-dependent activity without Nop10.
Therefore, we dissected the role of Nop10 and Gar1 for the guide-
independent tRNA modification by Cbf5. Our results clearly show
that Nop10 and Gar1 not only increase Cbf5’s affinity to tRNA, but
that they also enhance its catalytic activity.
Results
Multiple-turnover catalysis of tRNA modification by Cbf5 in
absence and presence of Nop10 and Gar1. In order to understand
the contribution of proteins Nop10 and Gar1 on the pseudouri-
dylation activity of Cbf5, a highly-purified Pyrococcus furiosus
model system was used, similarly to previous studies13–15. Each
protein was individually expressed in Escherichia coli, and cells
expressing the respective proteins were combined during cell open-
ing to allow for formation of protein complexes. Subsequently, the
individual proteins (Cbf5, Gar1) or protein complexes (Cbf5-Nop10,
Cbf5-Nop10-Gar1) were purified by affinity and size-exclusion
chromatography utilizing the hexa-histidine tag engineered onto
the N-terminus of Cbf5 or Gar1. This purification strategy is
essentially identical to previously published methods13. All proteins
were more than 95% pure as judged by SDS-PAGE. To study Cbf5’s
activity in modifying archaeal tRNA, P. furiosus tRNAAsp, a substrate
of Cbf517, was generated by in vitro transcription using [C5-3H]UTP
and subsequently purified by anion exchange chromatography.
To verify the activity of the in vitro reconstituted complexes, time
courses of pseudouridine formation were recorded at 70uC, which
has previously been shown to be the optimal temperature for Cbf517,
and under multiple turnover conditions, i.e. with lower enzyme
(10 nM) than substrate (1000 nM) concentration (Fig. 1). The extent
of pseudouridylation was determined using a well-established tri-
tium release assay detecting liberation of tritium from the C5 of
the uracil base upon formation of the new C-C glycosidic bond21.
No tritiumwas released from the tRNAunder these conditions in the
absence of proteins. Notably, more than 80% pseudouridine forma-
tion was observed after 60 min for the Cbf5-Nop10-Gar1 complex as
well as the Cbf5-Gar1 complex while the Cbf5-Nop10 complex
yielded 60% pseudouridine formation in 60 min. Interestingly,
Cbf5 alone only reached about 20% pseudouridylation after 60 min-
utes of incubation. This might be attributed to the general tendency
of free Cbf5 to precipitate as observed during purification. In general,
our findings are consistent with previous studies which showed an
increasing activity of Cbf5 upon addition of Nop10 alone, Gar1
alone, or both Nop10 and Gar1; the latter Cbf5-Nop10-Gar1 com-
plex representing the most active complex17–19. However all these
studies were conducted under single-turnover conditions using a
large excess of enzyme over substrate. Therefore, our findings
demonstrate for the first time that Cbf5 and its complexes with
Nop10 and Gar1 are able to catalyze tRNA modification in a mul-
tiple-turnover fashion. It furthermore reveals that all of the analyzed
complexes are capable of efficient product release in contrast to the
guide RNA-dependent function of Cbf5 where the reaction is limited
to a single round of catalysis when Gar1 is absent, presumably since
the product RNA cannot dissociate from the H/ACA small ribonu-
cleoprotein12. In summary, we are using a highly-active, purified
reconstituted in vitro system capable of multiple-turnover catalysis
for studying pseudouridylation by Cbf5 in presence and absence of
Nop10 and Gar1.
Steady-state kinetic analysis of tRNA modification by Cbf5. In
order to identify the role of Nop10 and Gar1 for tRNA modi-
fication by Cbf5, we have conducted steady-state kinetic experi-
ments utilizing the fully active Cbf5-Nop10-Gar1 complex as well
as complexes lacking either Nop10 or Gar1. We did not analyze the
Cbf5 enzyme alone due to its limited activity (Fig. 1). Based on these
experiments we have determined the catalytic constants (kcat) as well
as the Michaelis constants (KM), which respectively provide insights
into catalysis and interaction with the substrate RNA. Based on the
initial, linear phase of product formation using 10 nM enzyme, the
initial velocity (v0) of the reaction could be determined by linear
fitting (Fig. 2a). The respective experiments were conducted at
different tRNA concentrations ranging from 150 to 3000 nM to
determine the dependence of the initial velocity on the substrate
concentration (Fig. 2b–d). Fitting to a Michaelis-Menten equation
provided the steady-state kinetic parameters kcat and KM summa-
rized in Table 1. Interestingly, all three analyzed complexes exhibited
very similar behavior at low tRNA concentrations (, 300 nM
tRNA). However, at higher tRNA concentration, the initial velocity
of the Cbf5-Nop10 as well as the Cbf5-Gar1 catalyzed reaction did
increase only very slightly (Fig. 2 b and c). In contrast, the Cbf5-
Nop10-Gar1 complex showed a strong increase in initial velocity
with higher substrate tRNA concentrations up to a velocity of
180 nM min21 at 3000 nM tRNA without reaching saturation
(Fig. 2d). Thus, both Nop10 and Gar1 contribute significantly to
Cbf5’s activity in particular at high substrate concentrations. This
trend is confirmed by the quantitative analysis of the titrations, as the
kcat of the Cbf5-Nop10-Gar1 complex is 0.7 s21, more than threefold
higher than that of Cbf5-Gar1 (0.2 s21) and about six fold larger than
the kcat of the Cbf5-Nop10 complex (0.11 s21). Interestingly, the
effect of Nop10 and Gar1 on the Michaelis-Menten constant, KM,
Time, min
P
se
ud
ou
rid
in
e,
nM
0
200
10 4020 300 6050
400
800
600
Figure 1 | Time courses of pseudouridine formation by Cbf5 alone and in
the presence of Nop10 and Gar1. 1000 nM [3H]tRNA was incubated at
70uC with 10 nM Cbf5-Nop10-Gar1 (closed circles), Cbf5-Gar1
(triangles), Cbf5-Nop10 (squares) or Cbf5 alone (open circles). As a
control, 1000 nM [3H]tRNA was incubated in reaction buffer alone (open
squares). The extent of pseudouridine formation was quantified using the
tritium release assay.
www.nature.com/scientificreports
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is different than on kcat. The KM for tRNA decreases from about
4000 nM for the Cbf5-Nop10-Gar1 complex to 920 nM for Cbf5-
Gar1 and 260 nM for Cbf5-Nop10. This is surprising as on the first
view, this would suggest that the Cbf5-Nop10-Gar1 complex is less
efficient in interacting with substrate tRNA than the partially
assembled complexes.
Substrate binding by Cbf5 alone and in complex with Nop10 and/
or Gar1. In order to shed more light on the mechanism of substrate
binding by Cbf5-Nop10-Gar1 and subcomplexes thereof, nitro-
cellulose filtration assays were performed to determine the dissoci-
ation constants (KD) for tRNAAsp binding. To prevent modification
of the bound tRNA, we have constructed a catalytically inactive Cbf5
variant by mutating the catalytic aspartate 85 to asparagine (D85N).
This renders the protein completely inactive in pseudouridylation22
(data not shown) while retaining its RNA binding abilities (see
below). Subsequent to a 10 minute incubation of 10 nM [3H]tRNA
in the presence of excess protein, the reaction mixture was filtered
through a nitrocellulose membrane that retains protein and protein-
bound tRNA. After washing of the membrane with reaction buffer,
the amount of retained and therefore bound tRNA was determined
by scintillation counting of the nitrocellulose filters. In order to
assess the role of Nop10 and Gar1 for tRNA binding, we analyzed
not only the Cbf5D85N-Nop10-Gar1, the Cbf5D85N-Nop10 and
the Cbf5D85N-Gar1 complex, but also Cbf5D85N and Gar1 alone
as Gar1 has been shown to bind RNA23. For all proteins and protein
complexes tested, about 80% of the tRNA was bound to protein at
high protein concentrations (Fig. 3). Gar1 bound tRNA compara-
tively weakly (KD of 750 nM, Table 2), and Cbf5D85N alone bound
tRNA with an intermediate affinity (KD 5 235 nM). However, all
other complexes of Cbf5D85N with Nop10 and/or Gar1 displayed a
high affinity for tRNA ranging from 45 – 80 nM (Table 2). In com-
parison to Cbf5D85N alone, these results clearly show that both
Nop10 and Gar1 enhance Cbf5’s ability to bind tRNA to similar
extent. Furthermore, these experiments demonstrate that the com-
plete Cbf5-Nop10-Gar1 complex is fully capable of tight binding to
the substrate tRNA despite its high KM (Fig. 2 and Table 1).
The large difference between the KD and the KM can be explained
with the high catalytic activity of the Cbf5-Nop10-Gar1 complex.
Only for the classical Michaelis-Menten mechanism is the KD (5
k21/k1) equal to the KM, i.e. only if the catalytic rate constant (k2) is
low compared to dissociation of substrate (k21)24. This is not the case
for most enzymes including Cbf5-Nop10-Gar1 where KM is influ-
enced not only by the rate constants for substrate binding (k1, k21),
but also by the rate constant of catalysis (k2) or other subsequent
steps. For the relatively simple Briggs-Haldane mechanism, KM is
defined as (k21 1 k2)/k124. While the exact kinetic mechanism of
Cbf5-Nop10-Gar1 inmodifying tRNA is not known, our data are con-
sistent with a Briggs-Haldane mechanism. As the Cbf5-Nop10-Gar1
Figure 2 | Steady-state kinetic analysis of pseudouridylation by the Cbf5-Nop10-Gar1 complex and sub-complexes thereof. (a) Short time courses
using 1000 nM[3H]tRNA and 10 nMenzyme to determine the initial velocity (v0) of pseudouridine formation and its standard deviation by linear fitting.
Cbf5-Nop10-Gar1 (circles), Cbf5-Gar1 (triangles), Cbf5-Nop10 (squares). Similar time courses were recorded at different tRNA concentrations, and the
obtained initial velocities including standard deviations were plotted against the substrate concentration (b–d). Different complexes of Cbf5 were used as
enzymes: Cbf5-Nop10 (b), Cbf5-Gar1 (c), and Cbf5-Nop10-Gar1 (d). Fitting to theMichaelis-Menten equation (smooth lines) yielded values for kcat and
KM (see Table 1).
Table 1 | Kinetic parameters for tRNA modification by different
Cbf5 complexesa
KM, nM kcat, s21 kY, s21
Cbf5-Nop10-Gar1 4000 6 1700 0.7 6 0.2 . 0.2
Cbf5-Gar1 920 6 240 0.20 6 0.03 0.06 6 0.02
Cbf5-Nop10 260 6 70 0.11 6 0.01 0.07 6 0.02
Cbf5 n.d. n.d. 0.04 6 0.01
n.d. – not determined.
aEach value for KM, kcat and kY is reported together with its standard deviation obtained from data
fitting as described in the Methods.
www.nature.com/scientificreports
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complex has a high catalytic constant, kcat, which most likely reflects
the rate constant of catalysis, k2, it is expected that KM increases with
k2. In contrast, the catalytic constant, kcat, is rather low for the Cbf5-
Nop10 complex, and hence its KM value is in a similar order of
magnitude as the KD, i.e. the Cbf5-Nop10 complex might follow
the Michaelis-Menten mechanism. In conclusion, the high KM of
the Cbf5-Nop10-Gar1 complex seems to be a result of its high kcat
value, or in other words the high catalytic activity of the Cbf5-
Nop10-Gar1 complex is achieved by ‘‘sacrificing’’ the KM value for
tRNA. Notably, this property does not necessarily have to apply to
the complete H/ACA small ribonucleoprotein as it employs a differ-
ent mechanism for substrate RNA binding based on guide RNA.
Single-turnover tRNAmodification by Cbf5 and Cbf5 complexes.
Next, we asked whether Gar1 could influence the release of pro-
duct tRNA as it has been implicated in product release during the
Figure 3 | Substrate tRNA binding by Cbf5 in presence and absence of Nop10 and Gar1. To determine the affinity of Cbf5 and Cbf5-complexes to
unmodified substrate tRNA, [3H]tRNA was incubated with increasing concentrations of the catalytically inactive Cbf5 D85N variant and associated
proteins. The percentage of bound tRNA was recorded by nitrocellulose filtration and scintillation counting. The experiment was carried out with Gar1
alone (a), Cbf5D85N alone (b), Cbf5D85N-Nop10 (c), Cbf5D85N-Gar1 (d), and Cbf5D85N-Nop10-Gar1 (e). Fitting to a quadratic function (Materials
andMethods, smooth lines) provided the dissociation constant, KD, for the interaction of Cbf5 and its complexes with substrate tRNA (see Table 2). Here,
individual titrations are shown, but each experiment was repeated at least three times to determine the dissociation constants, KD, reported in Table 2.
Table 2 | Affinity of Cbf5 complexes to substrate and product
tRNAa
KD, nM (substrate tRNA) KD, nM (product tRNA)
Cbf5 235 6 65 n.d.
Cbf5-Nop10-Gar1 45 6 20 27 6 10
Cbf5-Gar1 80 6 25 105 6 25
Cbf5-Nop10 50 6 15 60 6 20
Gar1 750 6 300 n.d.
n.d. – not determined.
aEach KD is the average of at least three different nitrocellulose filtration experiments titrating
protein against tRNA. Each average KD value is reported together with the largest standard
deviation from individual filtration experiments (for details see Methods).
www.nature.com/scientificreports
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guide-dependent activity of the H/ACA small ribonucleoprotein12.
For this purpose, pseudouridylation assays were conducted under
single-turnover conditions, i.e. with an excess of enzyme (5 mM)
over [3H]tRNA (0.6 mM). Under these conditions, the tritium
release assay detects the appearance of the enzyme-product
complex as the active site is accessible to water and the released
tritium can easily escape the active site. Therefore, the measured
rate constant is independent of product release in contrast to the
kcat measured under multiple round conditions. If product release
is rate-limiting under the multiple turnover conditions, for example
upon omission of Gar1, the kcatwould be lower than the single-round
rate constant of pseudouridine formation (kY). It is therefore the aim
of these single-round experiments to assess whether product release
is limiting by comparing kY and kcat. For these experiments, very
short time courses have to be measured as the reaction is expected to
be rather fast. Usually we would achieve this by using the rapid-
mixing quench flow apparatus; however, this is not feasible at
70uC. Therefore, the experiments were performed by hand allow-
ing at least a rough estimation of single-round pseudouridylation
rate constants (kY). Again, all Cbf5 complexes with Nop10 and/or
Gar1 achieved 80% or more product formation in a short time
(Fig. 4). Interestingly, Cbf5 alone was able to form pseudouridines
with a rate of 0.04 s21 under these conditions, but failed to convert
more than 30% of all tRNAs which again might be explained by an
instability of Cbf5 during the course of the experiment. As expected
based on the kcat, the complete Cbf5-Nop10-Gar1 complex had
converted all substrate to product within the first 10 seconds, thus
indicating that the single-round rate constant is at least 0.2 s21 or
larger. Interestingly, upon omitting Gar1, the Cbf5-Nop10 complex
displayed a single-round rate constant of 0.07 s21 which is very
similar to the kcat value of 0.11 s21 for this complex given the
precision of the measurements (Table 1). This clearly demonstrates
that product release is fast for the Cbf5-Nop10 complex. Therefore,
Gar1 is not involved in tRNA product release in contrast to its
function in the guide-dependent reaction12. For the Cbf5-Gar1
complex, the single-round rate constant is 0.06 s21 and therefore
also in a comparable magnitude to the kcat (Table 1). This indicates
that Nop10 is also not involved in product release.
Interaction of Cbf5 complexes with modified product tRNA and
H/ACA guide RNA. Based on previous studies reporting that
pseudouridine synthases can bind modified product tRNA25, we
next examined whether this is also the case for Cbf5. To this end,
the nitrocellulose filtration assays with [3H]tRNA were repeated in
the presence of active, wild-type Cbf5 in complex with Nop10 and/or
Gar1. As shown in the single-turnover pseudouridylation assay
(Fig. 4), all uridines should be converted to pseudouridines by the
Cbf5-Nop10, Cbf5-Gar1 and Cbf5-Nop10-Gar1 complexes during
the 10 minute incubation period at 70uC allowing the measurement
of modified product tRNA binding. Interestingly, all Cbf5 complexes
again displayed relatively tight tRNA binding reaching maximal
binding at protein concentrations of about 100 nM (Fig. 5). Fitting
of the data revealed the dissociation constants (KD) as summarized in
Table 2. The comparison to the respective affinities for unmodified
substrate tRNA reveals that Cbf5 complexes with Nop10 and/or
Gar1 bind with similar affinities to substrate and product tRNA.
Notably, tight binding of the product tRNA does not exclude rapid
product release; instead it is likely that product binding is a dynamic
equilibrium with rapid dissociation and re-association of the tRNA.
Lastly, we were asking how the interaction of the Cbf5-Nop10-
Gar1 complex with tRNA compares to its interaction with H/ACA
guide RNA as it occurs in the archaeal cell. Therefore, [3H]-labeled
H/ACA guide RNA Pf426 was prepared and used in nitrocellulose
filtration assays with Cbf5-Nop10-Gar1. The titration revealed that
H/ACA guide RNA binds tightly to Cbf5-Nop10-Gar1 reaching the
end level already at 100 nM of protein. The dissociation constant for
the interaction of Cbf5-Nop10-Gar1 with H/ACA guide RNA Pf4 is
21 6 8 nM as determined in three independent experiments. Hence,
Cbf5-Nop10-Gar1 binds guide RNA as tight as tRNA (see Table 2).
Discussion
Here, we present the first quantitative analysis of guide-independent
pseudouridine formation by archaeal Cbf5 in presence and absence
of its accessory proteins Nop10 and Gar1. Our findings demonstrate
that both Nop10 and Gar1 enhance Cbf5’s catalytic activity.
Furthermore, they improve Cbf5’s interaction with its substrate
tRNA. In contrast to the guide-dependent reaction, Gar1 does not
affect product release by Cbf5. All Cbf5 complexes are capable of
tight-binding to both the substrate and the product tRNA. These
quantitative findings allow for the first time a detailed insight into
the role of the accessory proteins Nop10 and Gar1.
Our results unambiguously show that lack of eitherNop10 orGar1
from the full Cbf5-Nop10-Gar1 complex reduces the catalytic con-
stant, kcat, revealing a role of Nop10 and Gar1 in enhancing the
catalytic ability of Cbf5. In general, the active site of pseudouridine
synthases contains three residues that have been implicated in cata-
lysis: an asparatate that is essential for catalysis as well as a tyrosine
(phenylalanine in TruD) and an arginine or lysine interacting with
the catalytic aspartate1. Our findings raise the question of howNop10
and Gar1 can influence the active site of Cbf5.
The different crystal structures of Cbf5-Nop10-Gar1 support the
hypothesis that Nop10 and Gar1 may influence all three active site
residues of Cbf5 and may contribute to positioning of the substrate
tRNA. As seen in the crystal structures of Cbf5-Nop10-Gar1, Nop10
binds in the vicinity of Cbf5’s active site whereas Gar1 can interact
with Cbf5’s thumb loop, but is not close to the active site of Cbf5
(Fig. 6)13,27. Based on these structural constraints, it is highly unlikely
that either Nop10 or Gar1 contribute a residue directly to the active
site which is also in accordance with the observation that significant
catalytic activity is retained upon loss of Nop10 or Gar1. Instead, we
hypothesize that Nop10 and Gar1 are indirectly influencing Cbf5’s
activity. For Nop10, it has already been proposed based on the crystal
structures that it stabilizes the active site of Cbf528. Nop10’s linker
region directly interacts through a so-called proline spine with the
conserved motif I in Cbf5 which is located next to the active site and
contacts the catalytic aspartate residue29. Additionally, the N-
terminal domain, specifically the conserved tyrosine 14 of Nop10
(P. furiosus numbering as in Duan et al.12), contacts the conserved
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Figure 4 | Effect of Nop10 and Gar1 on a single-round of pseudouridine
formation by Cbf5. 0.6 mMof [3H]tRNAwas incubated with 5 mMof Cbf5
and accessory proteins at 70uC, and pseudouridine formation was
determined using the tritium release assay. Under these conditions, each
Cbf5 enzyme can only modify a single tRNA. The tRNA was reacted with
Cbf5-Nop10-Gar1 (closed circles), Cbf5-Gar1 (closed triangles), Cbf5-
Nop10 (closed squares), or Cbf5 alone (open circles). The time courses
were fit to a single-exponential equation to estimate the single-turnover
rate constant of pseudouridine formation, kY (Table 1).
www.nature.com/scientificreports
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valine 114 in b4 of Cbf5 which is next to the conserved tyrosine 113
residue that has been implicated in catalysis28. Hence the effect of
Nop10 on Cbf5’s catalytic ability might result from a stabilization of
motif I in Cbf5 and b4 thereby correctly positioning the active site
residues aspartate 85 and tyrosine 113 (Fig. 6). Gar1 contacts the C-
terminus of Cbf5’s helix 5 which contains arginine 184 at its N-
terminus that is the third of the active site residues. Additionally,
Gar1 can interact with Cbf5’s thumb loop in the so-called open
conformation13 and maintains interactions with Cbf5’s strand b7
preceding the thumb loop in the closed conformation12. As the
thumb loop interacts with substrate RNA in presence of guide
RNA13, it can be envisioned that Gar1’s interaction with b7 could
also help to correctly position tRNA in Cbf5’s active site (Fig. 6).
Thus, Gar1 could influence the active site geometry of Cbf5 by cor-
rectly positioning helix 5 of Cbf5 and thereby the catalytic arginine,
and it could indirectly enhance catalysis by substrate positioning
with the help of the thumb loop.
The finding that Nop10 and Gar1 enhance Cbf5’s catalytic activity
during tRNAmodification likely also applies to the guide-dependent
pseudouridylation byCbf5. Both the guide-dependent and the guide-
independent reaction analyzed here are taking place in the same
active site of Cbf5; and Nop10 and Gar1 interact in the same way
with Cbf5 in the absence and presence of guide RNA as evident upon
comparing the isolated Cbf5-Nop10-Gar1 structure and the full H/
ACA small ribonucleoprotein13,27. Therefore, we hypothesize that the
roles of Nop10 and Gar1 in stabilizing Cbf5’s active site during
catalysis also hold true for the guide-dependent reaction. Notably,
it would not have been possible to identify these functions of Nop10
and Gar1 by studying the guide-dependent reaction as lack of Nop10
completely inhibits pseudouridine formation14,15 and lack of Gar1
limits the reaction to a single round12. Our findings do not exclude
other roles of Nop10 and Gar1 in the guide-dependent reaction in
particular for substrate RNA binding and product release which
might be substantially different from Cbf5’s interactions with
tRNA.
Notably, Cbf5-Nop10-Gar1 displays a similar catalytic constant of
about 0.7 s21 to the rate constants of pseudouridylation by bacterial
pseudouridine synthases TruB, TruA and RluA (0.35 to 0.7 s21)11. It
has been previously discussed that this relatively low catalytic rate
constant will most likely apply to all bacterial stand-alone pseudour-
idine synthases. The findings for Cbf5-Nop10-Gar1 now suggest that
uniform slow catalysis is a general feature of pseudouridine synthases
that holds true also for complex pseudouridine synthases such as
Cbf5. Possibly, such a slow rate of catalysis is a result of the chemical
mechanism required for pseudouridine formation. Pseudouridy-
lation consists of at least cleavage of the glycosidic bond, rotation
of the uracil base and formation of the new C-C glycosidic bond, and
this reaction is presumably catalyzed by the same mechanism in all
pseudouridine synthases sharing a conserved catalytic domain and
conserved active site residues1. As this is a chemically complex reac-
tion, it might not be possible to enhance pseudouridine formation to
more than 0.35 – 0.7 s21.
The nitrocellulose filtration assays reveal high-affinity equilibrium
binding constants (KD) in the low nanomolar range for both sub-
strate and product tRNA and all Cbf5 complexes. Both Nop10 and
Gar1 are able to enhance Cbf5’s ability to bind tRNA as the KDs for
the protein complexes are between 27 and 105 nM while Cbf5 alone
binds tRNA with a KD of 235 nM (Table 2). Again, this improved
tRNA binding might be a result of the overall stabilization of Cbf5 by
Nop10 and Gar1. Furthermore, Nop10 could directly contribute to
Figure 5 | Binding ofmodified product tRNA in comparison toH/ACA guide RNA by Cbf5 in presence and absence of Nop10 andGar1. [3H]tRNA or
[3H]H/ACA guide RNAwas incubated at 70uC for 10minutes with increasing concentrations of wild-type, active Cbf5-Nop10-Gar1 as well as complexes
missing Nop10 or Gar1 followed by nitrocellulose filtration and scintillation counting to determine the percentage of bound product tRNA. The tRNA
experiment was performed with Cbf5-Nop10 (a), Cbf5-Gar1 (b), and Cbf5-Nop10-Gar1 (c). The H/ACA guide RNA was bound to Cbf5-Nop10-Gar1
(d). Smooth lines are the result of fitting to a quadratic function yielding the dissociation constants, KD, for product tRNA binding (see Table 2) and H/
ACA guide RNA binding (21 6 8 nM). Again individual, representative titrations are shown.
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tRNA binding as it also forms contacts to the guide RNA in the H/
ACA small ribonucleoprotein13. Gar1 does not contact the guide
RNA and might not be directly involved in tRNA binding; accord-
ingly, at least for product binding, Gar1’s effect on the affinity of Cbf5
for tRNA seems to be smaller than the effect of Nop10 (Table 2).
Overall, our findings suggest that, although tRNA is not the in vivo
substrate of Cbf5, Cbf5 has retained the ability to interact with tRNA
similarly as its bacterial homologue TruB. Interestingly, Cbf5 alone
and its complexes display an even higher affinity for tRNA than
TruB11,25. Based on a structural comparison of Cbf5 with TruB and
its interaction with tRNA13,30, it is likely that the tRNA binding site on
Cbf5 overlaps with the guide RNA binding site. Therefore, the high
tRNA affinity of Cbf5 might reflect the ability of Cbf5 to tightly bind
H/ACA guide RNA (Fig. 5d). Furthermore, it is not surprising that
binding of modified product tRNA to the Cbf5 complex is very
similar to binding of unmodified substrate tRNA as the introduction
of pseudouridine represents a relatively minor change to the overall
tRNA structure. Similarly, binding of product tRNA has previously
been observed for TruB25.
In contrast to Gar1’s function during the guide-dependent reac-
tion, Gar1 is not involved in product release fromCbf5 for the guide-
independent modification of tRNA12. Our data clearly show that
multiple rounds of catalysis can occur rapidly in the absence of
Gar1, i.e. for the Cbf5-Nop10 complex. Also, the single-round rate
constant of catalysis, kY, is similar to the multiple round catalytic
constant, kcat, for the Cbf5-Nop10 complex indicating that product
release is not rate-limiting. In fact, product release is also rapid for
Cbf5-Nop10-Gar1 and Cbf5-Nop10, i.e. rapid tRNA release seems to
be a general feature of the guide-independent reaction. This differ-
ential function of Gar1 for product release in the guide-dependent
and –independent RNA modification can best be explained by a
different mode of substrate binding. In the presence of a guide
RNA, the substrate RNA is held in place through several base-pairs.
In contrast, the tRNA directly interacts with the proteins, predomi-
nantly Cbf5 and maybe Nop10, and these contacts might be easier to
break during release of the product tRNA.
In summary, the first quantitative analysis of pseudouridine
formation by Cbf5-Nop10-Gar1 reported here reveals that both
Nop10 and Gar1 can stabilize the active site of Cbf5 thereby enhan-
cing its catalytic activity.We hypothesize that this is a general feature
of Nop10 andGar1which could also indirectly contribute to catalysis
during the guide-dependent reaction. Furthermore, we demonstrate
for the first time that Cbf5-Nop10-Gar1 complexes have very high
affinities for tRNA in the low nanomolar range, but are capable of
rapidly releasing modified product tRNA. As Cbf5-Nop10-Gar1 dis-
plays an equally high affinity to H/ACA guide RNA as to tRNA, we
suggest that Cbf5-Nop10-Gar1 might be mostly found bound to
guide RNA in the archaeal cell and might therefore not be available
formodifying tRNAwhich is instead catalyzed by Pus10 in vivo. This
quantitative characterization of the complex archaeal pseudouridine
synthase Cbf5 in tRNA modification paves the way for further stud-
ies into the mechanism of guide-RNA dependent pseudouridine
formation by the H/ACA small ribonucleoprotein complex.
Methods
Buffers and reagents.Reaction buffer: 20 mMHEPES-KOHpH 7.0, 1.5 mMMgCl2,
150 mM KCl, 0.1 mM EDTA. Nucleotide triphosphates and guanine
monophosphate for in vitro transcription, and inorganic pyrophosphatase were from
Sigma; all other enzymes were from Fermentas. Chemicals were purchased from
VWR, DNA oligos were obtained from IDT and [C5-3H] UTP (MT 553) was from
Moravek.
Molecular cloning and mutagenesis. The genes encoding the proteins Cbf5, Nop10,
Gar1 and Pus10 were amplified from P. furiosus genomic DNA (ATCC, 43587D-5)
using the following primers (restriction site in italics):
Cbf5 sense (BamHI) 59-GGATCCGGCGAGAGACGAGGTAAGAAG-39
Cbf5 antisense (SalI) 59-GTCGACTTAGCTTCTATCTCTTTTTTCCC-39
Nop10 sense (BglII) 59-CCCGAGATCTCAGGTTTAGGATAAGGAAGTGTC-39
Nop10 antisense (XhoI) 59-CATTCTCGAGTCATTTTTCCTTCCTCCCTA-39
Gar1 sense (histag, NheI) 59-ATGGCTAGCGAAAAACAGGGTGAAAAAATG-39
Gar1 sense (no his, NcoI) 59-GCGCCATGGGCGAAAAACAGGGTGAAAAAATG-39
Gar1 antisense (BamHI) 59-TTCGGATCCTCATCTATTCAGCCTTTTCTTC-39
Subsequently, the genes were inserted by blunt-end ligation into SmaI restricted
pUC19 plasmid. Using restriction sites added through the primers, the genes were
removed from the pUC19 plasmid and inserted into an expression vector which had
been double-restricted with the appropriate enzymes and gel purified. This generated
the following plasmids: pETDuet1-PfCbf5 (gene in multiple cloning site I including
an N-terminal hexahistidine tag), pETDuet1-PfNop10(nohis) (gene in multiple
cloning site II without tag), pET28a-PfGar1 (includingN-terminal hexahistidine tag),
and pET28a-PfGar1(nohis) (without tag used for purification in complex with Cbf5).
To generate catalytically inactive variant of Cbf5, quikchange mutagenesis was
applied to change the catalytic aspartate to asparagine generating plasmid pETDuet1-
PfCbf5D85N. All plasmids were verified by sequencing (Macrogen).
Protein expression and purification. For protein expression, plasmids were
individually transformed into Rosetta 2(DE3) competent E. coli cells (EMD
Bioscience). To express Cbf5 and Nop10, cells were grown in LB medium
supplemented with100 mg/mL ampicillin; for Gar1 expression, LBmedium contained
50 mg/mL kanamycin. At an OD600 of ,0.6, protein expression was induced by the
addition of isopropyl b-D-1-thiogalactopyranoside (IPTG) to a final concentration of
1mM. In case of Gar1, cells were transferred to 30uCprior to the induction. Cells were
Figure 6 | Contacts between Nop10 and Gar1 and the active site of Cbf5.
The upper panel shows the structure of the complete H/ACA small
ribonucleoprotein with guide RNA and L7Ae depicted in grey (PDB ID:
2HVY13); the active site of Cbf5 as shown below is indicated by the boxed
area. The active site residues of Cbf5 (Asp85, Tyr113, and Arg184) are
shown in red. Nop10 is depicted in cyan and Gar1 in purple. Residues of
Nop10 indicated in pink are in contact with Cbf5 residues shown in green
that are in the direct neighborhood of the active site residues Asp85 and
Tyr113. Gar1 contacts helix 5 of Cbf5 (yellow) that contains the active site
Arg184 at its N-terminus; furthermore Gar1 interacts with Cbf5’s b7
strand preceding the thumb loop (orange) which can interact with the
substrate RNA. These contacts can potentially contribute to the
stabilization of Cbf5’s active site by Nop10 and Gar1. The figure was
prepared using PyMol (www.pymol.org).
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harvested three hours after induction by centrifugation at 5,000 3g for 15 min, flash
frozen and stored at 280uC.
Cbf5 and Gar1 were individually purified. For purification of Cbf5-Nop10 and
Cbf5-Nop10-Gar1 complexes, cells were mixed to allow formation of the protein
complex during cell opening similar as in previous reports13. In all cases, cells were
resuspended in 5 mL/g Buffer A1 for purification of Cbf5-Nop10 and Cbf5-Nop10-
Gar1 (25 mM sodium phosphate buffer (pH 7.6), 1 M NaCl, 5% (v/v) glycerol,
30 mM imidazole and 0.1 mM phenylmethylsulfonyl fluoride (PMSF)) or Buffer A2
for purification of Cbf5 and Gar1 alone (20 mM Tris-HCl pH 8.0, 300 mM KCl,
5 mM b-mercaptoethanol, 5% (v/v) glycerol, 30 mM imidazole, 0.1 mM PMSF).
Cells were lysed for 30 min on ice by adding 1 mg/mL lysozyme followed by addition
of sodium deoxycholate (12.5 mg/g cells) and further incubation for 15 min on ice.
The solutionwas sonicated five times for 1 min each (intensity level 6, duty cycle 60%,
Branson Sonifier) and centrifuged for 45 min at 30,000 3g, 4uC. The lysate was then
subjected to heat denaturation at 75uC for 15 min followed by centrifugation for
30 min at 30,000 3g, 4uC. For purification of Cbf5 alone, the heat denaturation step
was omitted since we observed that this step rendered the protein inactive. The
cleared lysate was loaded onto a 5 mLNi21 Sepharose column (GE Healthcare) using
a BioLogic LP chromatography system (BioRad) and washed extensively with Buffer
A. The protein was subsequently eluted with a linear gradient (50 mL) to Buffer B
(same as A except for 500 mM imidazole and no PMSF). For purification of Cbf5,
glycerol was immediately added to fractions to a final concentration of 20% (v/v).
Peak fractions were analyzed by 15% SDS-PAGE for Cbf5 and Gar1 purifications or
16.5% Tris-Tricine PAGE for complexes containing Nop10, pooled and concentrated
by ultrafiltration (Vivaspin MWCO 30,000 or 10,000). Next, the protein was re-
buffered either by ultrafiltration or by size exclusion chromatography using a
Superdex 75 column (XK26/100 column, GE Healthcare) in Buffer C (20 mM
HEPES-KOHpH7.5, 600 mMKCl, 1 mMEDTA, 20% (v/v) glycerol) at a flow rate of
1 mL/min (BioLogic DuoFlow chromatography system). Peak fractions were con-
centrated as before, flash frozen and stored in aliquots at 280uC.
Protein concentration was determined photometrically at 280 nm using a molar
extinction coefficient of 46,410 M21 cm21 for Cbf5, 9,970 M21 cm21 for Nop10, and
11,460 M21 cm21 for Gar1 (calculated using ProtParam31), while concentration of
Gar1 alone was also determined at 210 nm using the extinction coefficient of
20.5 mg21 ml cm21. The catalytically inactive mutant (D85N) of Cbf5 was purified
either alone or in combination with Gar1 and/or Nop10, essentially in the same way
as explained above.
In vitro transcription and purification of tRNA and H/ACA guide RNA. A
plasmid, called pIDT-Smart-PftRNAAsp, encoding a T7 promoter followed by the
gene for P. furiosus tRNAAsp was purchased from Integrated DNA Technology. To
generate H/ACA guide RNA, the sequence for P. furiosus H/ACA guide RNA Pf4
(59-AAUGCCCCUCCCCUCUCACACCCCCGUGAGAAGUGAGCGGGGGG-
CGGUCGGGGAGGGGACAUCA-39)26 as well as a T7 promoter was assembled
using overlapping oligos and cloned into a pUC19 vector. The template for the in vitro
transcription of tRNAAsp and Pf4 guide RNA was generated by PCR amplification
from the corresponding plasmids using methylated reverse primers to precisely
terminate transcription32. The in vitro transcription was performed using the PCR
template (10% (v/v)) in transcription buffer (40 mM Tris-HCl pH 7.5, 15 mM
MgCl2, 2 mM spermidine, 10 mM NaCl, 10 mM DTT) with 3 mM ATP, CTP and
GTP each, and 0.1 mM [C5-3H]UTP (23.9 Ci/mmole), 5 mM GMP, 0.01 U/mL
inorganic pyrophosphatase, 0.3 mM T7 RNA Polymerase and 0.12 U/mL RNase
inhibitor at 30uC for 4 h. The H/ACA guide RNA was in vitro transcribed under
similar conditions at 20uC over night. Following the in vitro transcription, the
template was digested with 2 U/mL DNaseI (Fermentas) for 1 h at 37uC, and the
RNA was purified with a Nucleobond AX100 column (Macherey-Nagel) using
equilibration buffer R0 (100 mM Tris-acetate pH 6.3, 10 mM MgCl2, 15% (v/v)
ethanol), washing buffer R1 (R0 with 300 mM KCl) and elution buffer R3 (R0 with
1150 mM KCl). The RNA was concentrated by isopropanol precipitation and
dissolved in H2O. The tRNA concentration was determined photometrically at
260 nm using the extinction coefficient 53105 M21 cm21. The specific activity of the
purified [3H]tRNAAsp and [3H] guide RNA was determined by scintillation counting.
Nitrocellulose filtration. Prior to all experiments, [3H]tRNAAsp and proteins were
pre-incubated at 70uC for 5 min. To allow the tRNA to bind to protein, 5 or 10 nM
[3H]tRNAAsp was incubated with 0 – 700 nM protein or protein complex in reaction
buffer for 10 min at 70uC. The complete 50 mL reaction mixture was then filtered
through a nitrocellulose membrane followed by washing of the membrane with 1 mL
cold reaction buffer. Membranes were dissolved for 30 min in 10 mL EcoLite
scintillation cocktail (EcoLite (1), MP Biomedical), and the amount of tRNA bound
to the protein retained on the membrane was determined by scintillation counting
(Perkin-Elmer Tri-Carb 2800TR liquid scintillation analyzer). In order to obtain the
dissociation constant (KD), the increase in the fraction of bound tRNA as a function of
the protein concentration was analyzed by fitting to a quadratic equation with [RNA]
5 5 or 10 nM:
Pbound~Amp| KDz RNA½ z protein½ ð Þ=2{ KDz RNA½ z protein½ ð Þ2

4{ protein½ | RNA½ 0:5  
Where Pbound is the percentage of bound tRNA, and Amp is the amplitude or final
level of bound tRNA. Each titration was repeated at least three times; the KD and its
standard deviation was determined for each titration by fitting in GraphPad Prism.
The average KD including the largest standard deviation of individual titrations
(which is larger than the standard deviation between the KDs of individual titrations)
is reported in Table 2.
Tritium release assay. For Michaelis-Menten titrations, different concentrations of
[3H]tRNAAsp (100 – 3000 nM) were incubated with 10 nM enzyme in reaction buffer
plus 0.2% (w/v) bovine serum albumin at 70uC. For single-turnover experiments,
600 nM [3H]tRNAAsp were incubated with 5 mM enzyme at 70uC. Samples were
removed at the desired time points and added to 5% (w/v) activated charcoal (Norit A,
EMD, CX0655-1) in 0.1 MHCl. Following centrifugation at 10,0003g for 2 min, the
supernatant was added to 0.5 mL fresh 5% (w/v) activated charcoal in 0.1 M HCl,
mixed and centrifuged again. The supernatant was filtered through a glass wool
plugged in a 1 mL micropipet tip, and 0.8 mL of the resulting filtrate was then used
for scintillation counting in 4 mL EcoLite scintillation cocktail. Each time course was
repeated at least three times to determine the initial velocity, v0, by linear fitting. The
dependence of the initial rates v0 on the tRNA concentration was analyzed by fitting
the data in GraphPad Prism using the Michaelis-Menten equation
v0~Vmax S½ = KMz S½ ð Þ, and the catalytic constant, kcat, was determined by dividing
vmax by the enzyme concentration (10 nM). The single-turnover experiments were
analyzed by fitting the data to a single-exponential equation
Pseudouridine~Amp{Amp| exp {ky|t
 
where Amp represents the amplitude and kY is the single-turnover rate constant of
pseudouridine formation. In Table 1, the values for KM, kcat and kY are stated along
with the standard deviation for each parameter obtained by fitting in GraphPad
Prism.
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